Information for Our Community

Whether you are part of our community or are interested in joining us, we welcome you to WashU Medicine.

close  


Visit the News Hub

AACR honors WashU Medicine investigators

Three cancer researchers recognized for contributions to field

July 7, 2026

headshots of three researchersMatt Miller/WashU Medicine

Three WashU Medicine faculty members have received honors from the American Association for Cancer Research (AACR) for their contributions to the understanding and treatment of cancer.

The WashU Medicine investigators — Kenneth M. Murphy, MD, PhD; John F. DiPersio, MD, PhD; and Sheila A. Stewart, PhD — were recognized at the 2026 AACR Annual Meeting, held in April in San Diego. All are research members at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine.

Murphy, the Eugene Opie First Centennial Professor of Pathology and Immunology, received the 2026 American Association for Cancer Research-Cancer Research Institute (AACR-CRI) Lloyd J. Old Award in Cancer Immunology. Murphy’s groundbreaking work is focused on dendritic cells, a type of immune cell, seeking to understand how they develop and take on specialized roles in controlling the body’s immune response, especially to cancer cells.

DiPersio, the Virginia E. and Sam J. Golman Endowed Professor of Medicine who treats patients at Siteman, received the AACR’s Award for Outstanding Achievement in Blood Cancer Research, honoring his decades of innovations that have transformed the understanding and treatment of blood cancers. Over a long career, he has made outstanding contributions to improving stem cell transplantation, reducing sometimes life-threatening graft-versus-host disease, and to developing novel CAR-T cell therapies.

Stewart, the Gerty Cori Professor and vice chair of the Department of Cell Biology and Physiology, has been elected to the AACR Board of Directors and was sworn in at the April meeting. Her work is focused on how the stroma — the noncancerous portion of tumors — promotes cancer development.

Read more about Murphy’s, DiPersio’s and Stewart’s honors on the Siteman Cancer Center website.

About WashU Medicine

WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with 3,100 faculty. Its National Institutes of Health (NIH) research funding portfolio is the second largest among U.S. medical schools and has grown 78% since 2016. Together with institutional investment, WashU Medicine commits over $1.6 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently among the top five in the country, with more than 2,550 faculty physicians practicing at 200 locations. WashU Medicine physicians exclusively staff Barnes-Jewish and St. Louis Children’s hospitals — the academic hospitals of BJC HealthCare — and Siteman Cancer Center, a partnership between BJC HealthCare and WashU Medicine and the only National Cancer Institute-designated comprehensive cancer center in Missouri and southern Illinois. WashU Medicine physicians also treat patients at BJC’s community hospitals in our region. With a storied history in MD/PhD training, WashU Medicine recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.